🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Treatment of Phantom Limb Pain by Intensive Visual Simulation Therapy

RecruitingNAAges 18 Years - anyAllOslo Metropolitan University
NCT06483035 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Phantom limb pain (PLP) is reported by as much as 80 % of patients following an amputation. There is increasing knowledge of the relation between PLP and maladaptive changes in brain cortical regions. Research has shown that the sight of an "intact arm" moving in a mirror may reverse maladaptions (Mirror-therapy, MT) and reduce PLP. The current project will implement a digital and modernized version of MT, i.e. Intensive Visual Simulation Therapy (IVS-T). Pilot studies have shown promising results on pain reduction in people with phantom limb pain when using IVS-T. However, there is a lack of RCT studies on this patient population. This study is a 2-arm randomized controlled trial (RCT) investigating the effectiveness of IVS-T compared with usual care in person with unilateral upper- or lower limb amputation with chronic phantom limb pain. The primary aim of the study is to investigat

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Unilateral or bilateral lower limb/upper limb amputees * Adults \> 18 years of age, no age limit * A minimum of 12 months since amputation * Chronic PLP: \> 6 months * PLP intensity: \> 3 on the 0-10 VAS scale * Analgesic treatments must have been stable for the previous month * Stable prosthetic situation (ie, satisfaction with the fitting of the prosthesis) or being a non-user. * Adequate Norwegian language skills Exclusion Criteria: * Significant visual impairment / blind * Unable to follow instructions, i.e significant cognitive impairment.
💊

What it tests

  • Intensive Visual Simulation (IVS)
  • Usual Care (UC)
📍

Where

1 site
Oslo Metropolitan University
Oslo, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy